Ledger.Open graph →
SEC Form D · Amendment · filed April 15, 2016

Dauntless 1, Inc

Offering
$12.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

David Kabakoff, Ph.D · Menlo Park, CADirectorJoel Martin, Ph.D · San Diego, CAExec · DirectorMichael Powell, Ph.D · Menlo Park, CADirectorBernie D. Raven · Seattle, WADirectorRichard L. Block · Anchorage, AKExec · DirectorTakashi L. Azegami · Anchorage, AKDirectorScott C. Lincoln · Seattle, WADirectorRoger L. Moseley · San Francisco, CAExec · DirectorJohn L. Ramey · Anchorage, AKDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗